How to Manage Overseas Expenses Without Disrupting Your Monthly Budget 
Unitree Robotics IPO Enters Listing Review Stage; Total Value of Funds Held by Shoucheng Expected to Exceed RMB 8 Billion 
Procolored X one Kickstarter Campaign Surpasses $860,000, Demonstrating Strong Demand for Desktop Hybrid UV Printing and Laser Production 
Malaysia-Based ONE COMPANY Foundation Unveils ONE WALLET, a Keyless Telegram-Native Wallet on TON Manitoba Harvest Introduces Hemp Hearts Health Hack to Thrive During the Holidays
78% of People Surveyed Want More Holistic Health Support This Season Manitoba Harvest. Manitoba Harvest….
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline readout of clinical…
Codiak’s Engineered Exosomes Promote T Cell and Antibody Responses to SARS-CoV-2 in vivo, Supporting the Potential for a Broadly Protective Pan-Beta Coronavirus and Variant Vaccine
Preclinical data at World Vaccine & Immunotherapy Congress 2021 show broad immunogenicity and neutralization against…
Mindset Pharma to Participate in Stifel GMP’s The Future of Healthcare Conference on December 8th
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Dyne Therapeutics Announces Submission of IND Application to Initiate Clinical Trial of DYNE-251 for Duchenne Muscular Dystrophy
– DYNE-251, Dyne’s First DMD Program, is Being Developed for Patients with Mutations Amenable to…
Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac’s Type A Meeting with FDA on Treosulfan
NDA resubmission expected in second calendar quarter 2022 (previously anticipated timeline)Final FDA decision expected 2 to…
SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline
PPF Group provides funding to advance SOTIO through key clinical milestones Proceeds shall be used…
Immutep Reports Good Safety from First Five Patients in Triple Combination Therapy Efti Study, Insight-003
SYDNEY, AUSTRALIA, Dec. 02, 2021 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
Cocrystal Pharma to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow
BOTHELL, Wash., Dec. 02, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or…
Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances
Simcyp Simulator has been used to inform more than 250 label claims for 85+ novel…
Replimune Appoints Christy Oliger to its Board of Directors
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology…
Acepodia Raises $109 Million Series C Financing to Advance Development of First-in-Class Antibody Cell Effector Therapies
Visionary technology investor Samuel Chen to join Board of Directors ALAMEDA, Calif., Dec. 02, 2021…
GBT Supports the ASH Research Collaborative’s Data Hub Sickle Cell Disease Program
Grant of $400,000 to help expand sickle cell disease real-world data gathering in the U.S….
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting
SEATTLE, Dec. 02, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
Mersana Therapeutics Named to 2021 List of Top Places to Work in Massachusetts by The Boston Globe
CAMBRIDGE, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage…
Medolife Rx Announces Results of Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor Products
BURBANK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”),…
Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
BOSTON, Dec. 02, 2021 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology…
Better Choice to Participate at the 10th Annual ROTH Deer Valley Corporate Access Event on Thursday, December 9th
Management will also host a webinar on Friday, December 10th at 2:00 p.m. ET NEW…
Launch of Tilray’s Fast-Acting Oral Strips Highlights Commitment to Medical Cannabis Innovation and Patient Care
Aphria Branded Medical Cannabis Oral Strips Powered by QuickStrip™ Innovation Now Available to Patients Throughout…
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
Anticipate First Patient Dosing in Phase 1/2 Clinical Trial for XTX202, a Tumor-Selective IL-2, in…